7.9London

Wednesday, 27 November 2024

PET imaging validates use of common cholesterol drug to enhance HER2-targeted cancer therapy

A novel therapeutic approach that combines human epidermal growth receptor factor 2 (HER2)-targeted therapies with the cholesterol-lowering drug lovastatin can reduce the number of cancer treatments required to prevent tumor growth. Monitored by immuno-PET scans, this combination therapy has the potential to personalize treatment for cancer patients and spare them…

FDA launches new Digital Health Advisory Committee

The U.S. Food and Drug Administration on Wednesday announced the creation of a new Digital Health Advisory Committee, which will gather “experts throughout the field who can help ensure our regulation of these exciting tools maintains an appropriate pace while working within parameters of safety and effectiveness standards,” said Troy…

Genetic causes of Raynaud’s phenomenon identified

Reviewed Researchers at Queen Mary University of London’s Precision Healthcare Research Institute (PHURI) and the Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin have identified the genetic causes of Raynaud’s phenomenon. Their findings, published today (12 October) in Nature Communications, could lead to the first effective treatments for…

People in crisis do better with their pets, researchers say

Statistics from relevant research: In Australia, social return on investment for programs that support people experiencing a crisis to help keep their companion animal is $8.21 for each $1 invested, (Source: Emergency Animal Boarding: A Social Return on Investment) Even before the cost of living and rental market crisis, a…